Treating protracted corneal ulcers with UVA corneal collagen crosslinking: clinical cases

It has recently been proposed to use ultraviolet (UVA) corneal collagen crosslinking as an alternative method of treating bacterial ulcerative lesions of the cornea. Ambivalent results regarding the efficacy and safety of this method of treatment limit its implementation in clinical practice so far....

Full description

Saved in:
Bibliographic Details
Main Authors: E. V. Yani, E. N. Iomdina, V. V. Pozdniakova, V. A. Golikova, K. E. Seliverstova
Format: Article
Language:Russian
Published: Real Time Ltd 2021-09-01
Series:Российский офтальмологический журнал
Subjects:
Online Access:https://roj.igb.ru/jour/article/view/729
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849696594111234048
author E. V. Yani
E. N. Iomdina
V. V. Pozdniakova
V. A. Golikova
K. E. Seliverstova
author_facet E. V. Yani
E. N. Iomdina
V. V. Pozdniakova
V. A. Golikova
K. E. Seliverstova
author_sort E. V. Yani
collection DOAJ
description It has recently been proposed to use ultraviolet (UVA) corneal collagen crosslinking as an alternative method of treating bacterial ulcerative lesions of the cornea. Ambivalent results regarding the efficacy and safety of this method of treatment limit its implementation in clinical practice so far.The purpose of this work is to analyze three clinical cases involving the use of a new device for local UVA crosslinking in the complex treatment of bacterial corneal protracted-course ulcers with the suspected development of mixed fungal infection.Material and methods. For a dynamic follow-up of patients, we used biomicroscopy with a fluorescein test, photo registration and optical coherence tomography of the anterior part of the eye. Inflammatory changes were assessed using a point scale.Results. 3–5 procedures of local UVA exposure (with instillations of 0.1% riboflavin solution) lasting 3–5 minutes each and given with an interval of 2–4 days ensured stable and fast epithelialization of the cornea and a significant increase in visual acuity in the inflammatory process outcome.Conclusion. The first results of treating bacterial corneal ulcers using a new portable device for local UVA crosslinking have shown its high therapeutic efficiency and good prospects for further use in clinical practice.
format Article
id doaj-art-85cabd86fa484a4caf89791f2a7224fb
institution DOAJ
issn 2072-0076
2587-5760
language Russian
publishDate 2021-09-01
publisher Real Time Ltd
record_format Article
series Российский офтальмологический журнал
spelling doaj-art-85cabd86fa484a4caf89791f2a7224fb2025-08-20T03:19:24ZrusReal Time LtdРоссийский офтальмологический журнал2072-00762587-57602021-09-0114310611210.21516/2072-0076-2021-14-3-106-112384Treating protracted corneal ulcers with UVA corneal collagen crosslinking: clinical casesE. V. Yani0E. N. Iomdina1V. V. Pozdniakova2V. A. Golikova3K. E. Seliverstova4Helmholtz National Medical Research Center of Eye DiseasesHelmholtz National Medical Research Center of Eye DiseasesHelmholtz National Medical Research Center of Eye DiseasesHelmholtz National Medical Research Center of Eye DiseasesHelmholtz National Medical Research Center of Eye DiseasesIt has recently been proposed to use ultraviolet (UVA) corneal collagen crosslinking as an alternative method of treating bacterial ulcerative lesions of the cornea. Ambivalent results regarding the efficacy and safety of this method of treatment limit its implementation in clinical practice so far.The purpose of this work is to analyze three clinical cases involving the use of a new device for local UVA crosslinking in the complex treatment of bacterial corneal protracted-course ulcers with the suspected development of mixed fungal infection.Material and methods. For a dynamic follow-up of patients, we used biomicroscopy with a fluorescein test, photo registration and optical coherence tomography of the anterior part of the eye. Inflammatory changes were assessed using a point scale.Results. 3–5 procedures of local UVA exposure (with instillations of 0.1% riboflavin solution) lasting 3–5 minutes each and given with an interval of 2–4 days ensured stable and fast epithelialization of the cornea and a significant increase in visual acuity in the inflammatory process outcome.Conclusion. The first results of treating bacterial corneal ulcers using a new portable device for local UVA crosslinking have shown its high therapeutic efficiency and good prospects for further use in clinical practice.https://roj.igb.ru/jour/article/view/729corneal ulcertreatmentultraviolet crosslinkingdevice for local corneal collagen crosslinking
spellingShingle E. V. Yani
E. N. Iomdina
V. V. Pozdniakova
V. A. Golikova
K. E. Seliverstova
Treating protracted corneal ulcers with UVA corneal collagen crosslinking: clinical cases
Российский офтальмологический журнал
corneal ulcer
treatment
ultraviolet crosslinking
device for local corneal collagen crosslinking
title Treating protracted corneal ulcers with UVA corneal collagen crosslinking: clinical cases
title_full Treating protracted corneal ulcers with UVA corneal collagen crosslinking: clinical cases
title_fullStr Treating protracted corneal ulcers with UVA corneal collagen crosslinking: clinical cases
title_full_unstemmed Treating protracted corneal ulcers with UVA corneal collagen crosslinking: clinical cases
title_short Treating protracted corneal ulcers with UVA corneal collagen crosslinking: clinical cases
title_sort treating protracted corneal ulcers with uva corneal collagen crosslinking clinical cases
topic corneal ulcer
treatment
ultraviolet crosslinking
device for local corneal collagen crosslinking
url https://roj.igb.ru/jour/article/view/729
work_keys_str_mv AT evyani treatingprotractedcornealulcerswithuvacornealcollagencrosslinkingclinicalcases
AT eniomdina treatingprotractedcornealulcerswithuvacornealcollagencrosslinkingclinicalcases
AT vvpozdniakova treatingprotractedcornealulcerswithuvacornealcollagencrosslinkingclinicalcases
AT vagolikova treatingprotractedcornealulcerswithuvacornealcollagencrosslinkingclinicalcases
AT keseliverstova treatingprotractedcornealulcerswithuvacornealcollagencrosslinkingclinicalcases